1. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. A Gynecologic Oncology Group Study. Surgical pathologic spread patterns of endometrial cancer. Cancer. 1987; 60:8 Suppl. 2035–2041.
2. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40:55–65.
3. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res. 2014; 40:301–311.
4. SGO Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, et al. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol. 2014; 134:385–392.
5. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, et al. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012; 127:525–531.
6. Cacciatore B, Lehtovirta P, Wahlstrom T, Ylanen K, Ylostalo P. Contribution of vaginal scanning to sonographic evaluation of endometrial cancer invasion. Acta Oncol. 1989; 28:585–588.
7. Cagnazzo G, D'Addario V, Martinelli G, Lastilla G. Depth of myometrial invasion in endometrial cancer: preoperative assessment by transvaginal ultrasonography and magnetic resonance imaging. Ultrasound Obstet Gynecol. 1992; 2:40–43.
8. Osmers RG, Osmers M, Kuhn W. Prognostic value of transvaginal sonography in asymptomatic endometrial cancers. Ultrasound Obstet Gynecol. 1995; 6:103–107.
9. van Doorn HC, van der Zee AG, Peeters PH, Kroeks MV, van Eijkeren MA. Preoperative selection of patients with low-stage endometrial cancer at high risk of pelvic lymph node metastases. Int J Gynecol Cancer. 2002; 12:144–148.
10. Savelli L, Ceccarini M, Ludovisi M, Fruscella E, De Iaco PA, Salizzoni E, et al. Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008; 31:560–566.
11. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer: a multicenter prospective comparative study. Gynecol Oncol. 2013; 128:300–308.
12. Gordon AN, Fleischer AC, Reed GW. Depth of myometrial invasion in endometrial cancer: preoperative assessment by transvaginal ultrasonography. Gynecol Oncol. 1990; 39:321–327.
13. Karlsson B, Norstrom A, Granberg S, Wikland M. The use of endovaginal ultrasound to diagnose invasion of endometrial carcinoma. Ultrasound Obstet Gynecol. 1992; 2:35–39.
14. Fotopoulou C, Sehouli J, Schefold JC, Wolf C, Denkert C, Lichtenegger W, et al. Preoperative transvaginal ultrasound (TVS) in the description of pelvic tumor spread in endometrial cancer: results of a prospective study. Anticancer Res. 2008; 28(4C):2453–2458.
15. De Smet F, De Brabanter J, Van den Bosch T, Pochet N, Amant F, Van Holsbeke C, et al. New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography. Ultrasound Obstet Gynecol. 2006; 27:664–671.
16. Van Holsbeke C, Ameye L, Testa AC, Mascilini F, Lindqvist P, Fischerova D, et al. Development and external validation of new ultrasound-based mathematical models for preoperative prediction of high-risk endometrial cancer. Ultrasound Obstet Gynecol. 2014; 43:586–595.
17. Alcazar JL, Galvan R, Albela S, Martinez S, Pahisa J, Jurado M, et al. Assessing myometrial infiltration by endometrial cancer: uterine virtual navigation with three-dimensional US. Radiology. 2009; 250:776–783.
18. Mascilini F, Testa AC, Van Holsbeke C, Ameye L, Timmerman D, Epstein E. Evaluating myometrial and cervical invasion in women with endometrial cancer: comparing subjective assessment with objective measurement techniques. Ultrasound Obstet Gynecol. 2013; 42:353–358.
19. Alcazar JL, Pineda L, Caparros M, Utrilla-Layna J, Juez L, Minguez JA, et al. Transvaginal/transrectal ultrasound for preoperative identification of high-risk cases in well or moderately differentiated endometrioid carcinoma of the endometrium. Ultrasound Obstet Gynecol. 2015; 05. 29. [Epub]. DOI:
10.1002/uog.14912.
20. Lewin SN. Revised FIGO staging system for endometrial cancer. Clin Obstet Gynecol. 2011; 54:215–218.
21. Eriksson LS, Lindqvist PG, Floter Radestad A, Dueholm M, Fischerova D, Franchi D, et al. Transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer: interobserver reproducibility among ultrasound experts and gynecologists. Ultrasound Obstet Gynecol. 2015; 45:476–482.
22. Prompeler HJ, Madjar H, du Bois A, Lattermann U, Wilhelm C, Kommoss F, et al. Transvaginal sonography of myometrial invasion depth in endometrial cancer. Acta Obstet Gynecol Scand. 1994; 73:343–346.
23. Weber G, Merz E, Bahlmann F, Mitze M, Weikel W, Knapstein PG. Assessment of myometrial infiltration and preoperative staging by transvaginal ultrasound in patients with endometrial carcinoma. Ultrasound Obstet Gynecol. 1995; 6:362–367.
24. Gabrielli S, Marabini A, Bevini M, Linsalata I, Falco P, Milano V, et al. Transvaginal sonography vs. hysteroscopy in the preoperative staging of endometrial carcinoma. Ultrasound Obstet Gynecol. 1996; 7:443–446.
25. Sawicki W, Spiewankiewicz B, Stelmachow J, Cendrowski K. The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer. Eur J Gynaecol Oncol. 2003; 24:293–298.
26. Akbayir O, Corbacioglu A, Numanoglu C, Guleroglu FY, Ulker V, Akyol A, et al. Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma by transvaginal ultrasound. Gynecol Oncol. 2011; 122:600–603.